tiprankstipranks
Trending News
More News >
M3 Inc (JP:2413)
:2413
Japanese Market

M3 (2413) Stock Forecast & Price Target

Compare
3 Followers
See the Price Targets and Ratings of:

2413 Financial Forecast

2413 Earnings Forecast

Next quarter’s earnings estimate for 2413 is ¥22.14 with a range of ¥20.88 to ¥23.55. The previous quarter’s EPS was ¥16.03. 2413 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 2413 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2413 is ¥22.14 with a range of ¥20.88 to ¥23.55. The previous quarter’s EPS was ¥16.03. 2413 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 2413 has Performed in-line its overall industry.

2413 Sales Forecast

Next quarter’s sales forecast for 2413 is ¥96.02B with a range of ¥91.60B to ¥99.07B. The previous quarter’s sales results were ¥84.69B. 2413 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 2413 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2413 is ¥96.02B with a range of ¥91.60B to ¥99.07B. The previous quarter’s sales results were ¥84.69B. 2413 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 2413 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on JP:2413
Goldman Sachs
Goldman Sachs
Hold
Downgraded
10/09/25
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (NASDAQ: TARA), Kura Oncology (NASDAQ: KURA) and M3 (Other OTC: MTHRF)
Morgan Stanley Analyst forecast on JP:2413
Morgan Stanley
Morgan Stanley
¥1,900¥2,800
Buy
29.81%
Upside
Upgraded
09/27/25
M3 (MTHRF) was upgraded to a Buy Rating at Morgan Stanley
Citi
¥2,300
Hold
6.63%
Upside
Downgraded
08/28/25
M3 (MTHRF) was downgraded to a Hold Rating at Citi
Nomura
¥2,800¥3,000
Buy
39.08%
Upside
Reiterated
08/20/25
Nomura Sticks to Its Buy Rating for M3 (MTHRF)
UBS
¥1,980¥2,840
Buy
31.66%
Upside
Upgraded
08/13/25
UBS upgrades M3 (MTHRF) to a Buy
J.P. Morgan Analyst forecast on JP:2413
J.P. Morgan
J.P. Morgan
¥2,300
Buy
6.63%
Upside
Initiated
07/07/25
J.P. Morgan Initiates a Buy Rating on M3 (MTHRF)
Jefferies
¥1,600¥1,900
Hold
-11.91%
Downside
Reiterated
06/30/25
Jefferies Remains a Hold on M3 (MTHRF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on JP:2413
Goldman Sachs
Goldman Sachs
Hold
Downgraded
10/09/25
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (NASDAQ: TARA), Kura Oncology (NASDAQ: KURA) and M3 (Other OTC: MTHRF)
Morgan Stanley Analyst forecast on JP:2413
Morgan Stanley
Morgan Stanley
¥1,900¥2,800
Buy
29.81%
Upside
Upgraded
09/27/25
M3 (MTHRF) was upgraded to a Buy Rating at Morgan Stanley
Citi
¥2,300
Hold
6.63%
Upside
Downgraded
08/28/25
M3 (MTHRF) was downgraded to a Hold Rating at Citi
Nomura
¥2,800¥3,000
Buy
39.08%
Upside
Reiterated
08/20/25
Nomura Sticks to Its Buy Rating for M3 (MTHRF)
UBS
¥1,980¥2,840
Buy
31.66%
Upside
Upgraded
08/13/25
UBS upgrades M3 (MTHRF) to a Buy
J.P. Morgan Analyst forecast on JP:2413
J.P. Morgan
J.P. Morgan
¥2,300
Buy
6.63%
Upside
Initiated
07/07/25
J.P. Morgan Initiates a Buy Rating on M3 (MTHRF)
Jefferies
¥1,600¥1,900
Hold
-11.91%
Downside
Reiterated
06/30/25
Jefferies Remains a Hold on M3 (MTHRF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering M3

3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+12.10%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +12.10% per trade.
1 Year
Success Rate
5/7 ratings generated profit
71%
Average Return
+19.40%
reiterated a buy rating 5 months ago
Copying Kyoichiro Shigemura's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +19.40% per trade.
2 Years
xxx
Success Rate
5/7 ratings generated profit
71%
Average Return
+15.90%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +15.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2413 Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Oct 25
Nov 25
Dec 25
Strong Buy
6
9
9
6
2
Buy
0
0
0
0
0
Hold
3
4
4
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
13
13
8
3
In the current month, 2413 has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 2413 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

2413 Stock Forecast FAQ

What is JP:2413’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:2413’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:2413, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is M3 Inc a Buy, Sell or Hold?
      M3 Inc has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is M3 Inc’s share price target?
        Currently, no data Available
        What do analysts say about M3 Inc?
        M3 Inc’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of M3 Inc?
          To buy shares of JP:2413, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.